Strengthening America's Biotech Future: Strategies for Enhancing FDA as Global Gold Standard
•The FDA is undergoing a strategic reevaluation of its policies under new leadership, prompted by rapid advancements in science and technology.
•Now is the time for FDA to pursue a proactive policy agenda that balances its dual mission: safeguarding public health and promoting timely access to safe and effective medical products.
•Collaboration with industry, academics, and patients enables the Agency to harness the expertise necessary to lead the innovation ecosystem.
•By embracing its role as both gatekeeper and catalyst, the FDA can foster a regulatory environment that empowers progress in bringing meaningful treatments and cures to the American people.
•Maintaining global leadership as the regulatory gold standard is essential for American health, safety and prosperity.
